XOMA News and Press, XOMA Corporation From 03/07/19

XOMA (NASDAQ: XOMA ): Q4 GAAP EPS of -$0.35. More news on: XOMA Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...

Added seven new partner-funded programs in 2018 with potential for milestone and royalty payments Current cash balance sufficient to fund operations for multiple years EMERYVILLE, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) announced its fourth quarter a...

EMERYVILLE, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today its Chief Executive Officer, Jim Neal, will present an update about the company’s business at the Cowen and Company 39 th Annual Health Care Conference in Boston, Massachusetts. &#...

EMERYVILLE, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today it has received a $5.5 million payment from Rezolute, Inc., related to the Companies’ 2017 license agreement, as most recently amended on January 7, 2019. “Our business mod...

XOMA (NASDAQ: XOMA ) initiates a $20M subscription rights offering for holders of its common stock and Series X preferred stock who will be entitled to purchase XOMA common shares at $13 per share. More news on: XOMA Corporation, Healthcare stocks news, Read more ...

XOMA (NASDAQ: XOMA ): Q3 GAAP EPS of -$0.55 misses by $0.40 . More news on: XOMA Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...

Rights Offering will be available to all shareholders of record on November 16, 2018 $20 million to be raised Fully backstopped by BVF Partners L.P. EMERYVILLE, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Companyȁ...

EMERYVILLE, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator, today announced its third quarter 2018 financial results.  “The third quarter of 2018 was exciting for XOMA, as we completed our first royalty and milest...

Experienced Industry Executives Provide Company with Broad Life Science Industry Expertise Including Drug Development and Commercialization CARLSBAD, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Leading BioSciences, a drug development company focused on improving human health through the...

NEW YORK, Oct. 25, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Middlesex Water Company (NASDAQ:MSEX), On Deck Capital, Inc. (NYSE:ONDK),...